JW Asset Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

JW Asset Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-289,664	Closed	-$434K	–	23
2018 Q1	$434K	Hold	289,664	–	–	0.43%	19
2017 Q4	$411K	Hold	289,664	–	–	0.44%	20
2017 Q3	$663K	Sell	289,664 -30,000	-9%	-$40.2K	0.49%	23
2017 Q2	$432K	Sell	319,664 -1,112,785	-78%	-$1.61M	0.28%	29
2017 Q1	$3.06M	Sell	1,432,449 -1,247,691	-47%	-$4.69M	0.64%	18
2016 Q4	$11.8M	Buy	2,680,140 +65,000	+2%	+$309K	7.87%	4
2016 Q3	$12.7M	Sell	2,615,140 -122,000	-4%	-$556K	8.73%	3
2016 Q2	$9.03M	Buy	2,737,140 +900,765	+49%	+$3.4M	7.18%	6
2016 Q1	$6.52M	Buy	+1,836,375	New	+$9.47M	4.26%	7

Other funds holding ARLZ

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

PCM

PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

SCP

Silverleafe Capital Partners Germantown, Tennessee $367M AUM 37.49% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

JW Asset Management's ARLZ Position: Q2 2018 in Review

JW Asset Management sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2018, closing a stake of 289,664 shares — an estimated $434K sold.

JW Asset Management first reported a position in ARLZ in Q1 2016 and held it in 9 quarters. The position peaked at $12.7M in Q3 2016. 48 funds tracked by Wall St. Rank hold ARLZ as of Q2 2018.

JW Asset Management reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
JW Asset Management sold 289,664 Aralez Pharmaceuticals Inc. shares in Q2 2018, an estimated $434K.
JW Asset Management first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 9 quarters.
JW Asset Management's Aralez Pharmaceuticals Inc. position peaked at $12.7M in Q3 2016.
48 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2018.

Based on JW Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.